Free Trial

Simplify Propel Opportunities ETF Rating

$15.51 -0.09 (-0.58%)
As of 04:10 PM Eastern

Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

SURI Aggregate Rating

Moderate Buy
2.66

Holdings in SURI have an aggregate rating of Moderate Buy based on 73 analyst ratings issued in the past year covering 13 companies (92.5% of the portfolio).

SURI Aggregate Price Target

$15.73
High Prediction$15.73
Average Prediction$15.73
Low Prediction$15.73

Holdings in SURI have an aggregate price target of $15.73 and a range of $15.73 to $15.73 covering 13 companies (92.5% of the portfolio).

SURI Consensus Ratings of Holdings

Strong Buy
1 Strong Buy rating(s)
Buy
7 Buy rating(s)
Moderate Buy
2 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Simplify Propel Opportunities ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 13 SURI Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
37.57%
Plains GP Holdings, L.P. stock logo
PAGP
Plains GP
$20.01
+1.5%
2.2818 of 5 stars
2.38$20.88 4.3%8Positive News
13.79%
Pathward Financial, Inc. stock logo
CASH
Pathward Financial
$80.93
-2.0%
3.8579 of 5 stars
2.50$91.00 12.4%2Positive News
Upcoming Earnings
11.20%
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$52.09
-4.1%
3.6862 of 5 stars
3.00$82.50 58.4%6
7.15%
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
$7.95
-4.4%
4.3054 of 5 stars
3.00$17.50 120.1%6
4.78%
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$6.59
-0.6%
3.8485 of 5 stars
3.00$19.25 192.1%5
4.10%
Achieve Life Sciences, Inc. stock logo
ACHV
Achieve Life Sciences
$2.68
-2.5%
3.1513 of 5 stars
3.50$14.33 434.8%4Positive News
2.83%
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
$1.82
-3.7%
3.5938 of 5 stars
3.00$7.80 328.6%5
2.77%
Applied Therapeutics Inc. stock logo
APLT
Applied Therapeutics
$0.46
-1.7%
4.5504 of 5 stars
2.50$6.10 1,220.6%6Positive News
2.75%
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
$12.07
-4.7%
3.1134 of 5 stars
3.11$23.71 96.5%9Analyst Revision
2.30%
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
$1.58
-4.2%
2.7814 of 5 stars
2.40$7.00 343.0%5Analyst Revision
1.80%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.25
-0.6%
2.619 of 5 stars
3.00$24.00 113.3%4News Coverage
0.97%
Athira Pharma, Inc. stock logo
ATHA
Athira Pharma
$0.41
+3.8%
3.7794 of 5 stars
2.00$11.25 2,657.4%4Positive News
Gap Up
0.46%
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$6.88
-3.9%
2.5663 of 5 stars
3.11$22.56 227.8%9Trending News
Analyst Revision
Gap Down

This page (NYSEARCA:SURI) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners